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 THESIS ABSTRACT 
Name: Nidal Y. M. Abu-Thabit. 
Title: Synthesis of 2-imino-2-oxo-1,3,2-oxazaphosphorinanes. 
Major Field: Chemistry 
Date of Degree: May/2005 
The thesis outlines the development of suitable methodology in order to prepare 2-
imino-1,3,2-oxazaphosphorinanes. α-Methylbenzylamines were converted to the 
corresponding of 2-amino-2-oxo-1,3,2-oxazaphosphorinanes with good overall yields. X-
ray structures were obtained for both (2R)-chloro-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane and racemic 2-(R)-amino-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane. This conformational study clearly indicated that the exo cyclic P=O 
is equatorial whereas the chlorine and amino groups are axial.  
Aldimines were obtained upon heating the 2-amino-2-oxo-1,3,2-
oxazaphosphorinanes under reflux in dichloromethane for 24 hours with two equivalents 
of 4-substituted benzaldehyde derivatives and five equivalents of titanium (IV) ethoxide. 
However, five equivalents of acetophenone and ten equivalents of titanium (IV) ethoxide 
and heating under reflux in toluene were necessary for the synthesis of the corresponding 
ketimine derivative. This novel class of activated imine underwent a diastereoselective 
1,4-addition reaction with diethylaluminium cyanide (48% de). The major addition 
product was obtained in a diastereomerically pure form upon recrystallization from ethyl 
acetate and hexane. 
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   ﻟﺮﺳﺎﻟﺔا ﻣﻠﺨﺺ
  .ﺖــــﻤﺪ أﺑﻮ ﺛﺎﺑـــﻒ ﻣﺤــﺎل ﻳﻮﺳــﻧﻀ: اﻻﺳـــــــــــــــﻢ
  .)senanirohpsohpazaxo-2,3,1-onimi-2(ﺎت ـــــﻊ ﻣﺮآﺒــــﺗﺼﻨﻴ: اﻟﺮﺳﺎﻟﺔ ﻋﻨﻮان
  ﺎءـــﻤﻴـــاﻟﻜﻴ: اﻟﺘﺨﺼــــــــﺺ
  5002/  ــﺎﻳـﻮ ــﻣ: اﻟﺘﺨــﺮج ﺗﺎرﻳﺦ
ﺗﻢ .  )senanirohpsohpazaxo-2,3,1-onimi-2 (ان اﻻﻃﺮوﺣﺔ ﺗﺘﻨﺎول ﺗﻄﻮﻳﺮ ﻃﺮﻳﻘﺔ ﻣﻨﺎﺳﺒﺔ ﻟﺘﺤﻀﻴﺮ ﻣﺮآﺒﺎت
ﺗﻢ اﻟﺤﺼﻮل .  ﺑﻨﺴﺐ ﺟﻴﺪةsenanirohpsohpazaxo-2,3,1-onimi-2 اﻟﻰ senimalyzneblyhteM-αﺗﺤﻮﻳﻞ 
-2,3,1-oxo-2-]lyzneblyhtem-α-)R([-3-orolhc-)R2(ﻋﻠﻰ اﻟﺸﻜﻞ اﻟﺒﻨﻠﺌﻲ ﺑﻮاﺳﻄﺔ اﻻﺷﻌﺔ اﻟﺴﻴﻨﻴﺔ ﻟﻠﻤﺮآﺒﺎت 
-2,3,1-oxo-2-]lyzneblyhtem-α-)R([-3-onima-)R(-2 cimecar dna enanirohpsohpazaxo
ﻟﻠﺸﻜﻞ اﻟﺘﺮآﻴﺒﻲ ان اﻟﺮاﺑﻄﻪ اﻟﻤﻀﺎﻋﻔﺔ ﺑﻴﻦ اﻷآﺴﺠﻴﻦ ﺧﺎرج ﻟﻘﺪأوﺿﺤﺖ هﺪﻩ اﻟﺪراﺳﺔ . enanirohpsohpazaxo
 ﺑﻴﻨﻤﺎ ﺗﻜﻮن ﻣﺠﻤﻮﻋﺘﺎ اﻷﻣﻴﻦ و اﻟﻜﻠﻮر ﻓﻲ وﺿﻊ ﻋﺎﻣﻮدي  (lairotauqe)اﻟﺤﻠﻘﺔ  و اﻟﻔﺴﻔﻮر ﺗﻜﻮن ﻓﻲ وﺿﻊ ﻣﺎﺋﻞ 
  (.laixa)
 ﺳﺎﻋﺔ ﻓﻲ ﺛﻨﺎﺋﻲ آﻠﻮرﻳﺪ 42ﻟﻤﺪة  senanirohpsohpazaxo-2,3,1-onimi-2ﻋﻠﻰ اﻷﻟﺪأﻣﻴﻦ ﺑﺘﺴﺨﻴﻦ ﺗﻢ اﻟﺤﺼﻮل 
آﺎن ﻣﻦ ﺑﻴﻨﻤﺎ . (VI)اﻟﻤﻴﺜﻴﻞ ﺑﺎﺳﺘﺨﺪام ﻣﻜﺎﻓﺌﻴﻦ ﻣﻦ ﻣﺸﺘﻘﺎت اﻟﺒﻨﺰاﻟﺪﻳﻬﺎﻳﺪ ﻣﻊ ﺧﻤﺲ ﻣﻜﺎﻓﺌﺎت ﻣﻦ اﻟﺘﻴﺘﺎﻧﻴﻮم اﻷﻳﺜﻴﻠﻲ 
 42وﺑﺎﻟﺘﺴﺨﻴﻦ ل ( VI)ﺎﻧﻴﻮم اﻷﻳﺜﻴﻠﻲ اﺳﺘﺨﺪام ﺧﻤﺲ ﻣﻜﺎﻓﺌﺎت ﻣﻦ اﻷﺳﻴﺘﻮﻓﻴﻨﻮن و ﻋﺸﺮ ﻣﻜﺎﻓﺌﻠﺖ ﻣﻦ اﻟﺘﻴﺘاﻟﻀﺮوري 
ﺗﻤﺖ اﺿﺎﻓﺔ اﻟﺪﻳﺎﻳﺜﻴﻞ اﻟﻮﻣﻴﻨﻴﻮم ﺳﻴﺎﻧﻴﺪ ﻟﻬﺪا اﻟﻨﻮع اﻟﻔﺮﻳﺪ ﻣﻦ ﻣﺸﺘﻘﺎت . ﺳﺎﻋﻪ ﻓﻲ اﻟﺘﻮﻟﻴﻮﻳﻦ ﻟﺘﺤﻀﻴﺮ ﻣﺸﺘﻘﺔ اﻟﻜﻴﺘﺎﻣﻴﻦ
وﺗﻢ ﻓﺼﻞ اﻟﻤﺘﻤﺎﺛﻞ اﻟﺮﺋﻴﺴﻲ ﺑﺸﻜﻞ ﻧﻘﻲ ﺑﻮاﺳﻄﺔ اﻟﺘﺮﺳﻴﺐ ﻣﻦ ﻣﺤﻠﻮل اﻟﻴﺜﻴﻞ .  (e.d %84)اﻷﻳﻤﻴﻨﺎت ﺑﺸﻜﻞ ﻏﻴﺮ ﻣﺘﻤﺎﺛﻞ 
 أﺳﻴﺘﺎت و اﻟﻬﻜﺴﺎن
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 CHAPTER 1  
1. INTRODUCTION  
1.1 Literature Review 
There is an ever increasing demand for enantiomerically pure compounds, 
especially from the pharmaceutical industry, which must comply with stricter regulations 
imposed by the authorities. The world-wide sale of single enantiomer drugs in 2001 
amounts to $147 billion, or approximately 36% of the total market of pharmaceutical 
products.1 To meet this demand asymmetric synthesis, the stereoselective synthesis of 
enantiopure materials, has rapidly developed into one of the most important fields of 
chemical research.  
Stereoselective synthesis can be performed in three different ways. The first is 
under substrate control using chiral auxiliaries, the second is under reagent control and the 
third utilizes chiral catalysts. This thesis will outline the novel utilization of the 
oxazaphosphorinane chiral auxiliary. 
1.1.1 Oxazaphosphorinanes 
 The 2-oxo-1,3,2-oxazaphosphorinane ring system is found in many biologically 
active molecules. Several cancer drugs such as cyclophosphamide (1a), isophosphamide 
(1b) and triphosphamide (1c) contain this ring system (Figure 1).2
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N
PO Z
R
a) R=H, Z=N(CH2CH2Cl)2
b) R= CH2CH2Cl, Z=NHCH2CH2Cl
c) R= CH2CH2Cl, Z=N(CH2CH2Cl)2
(1)
O
 
Figure 1 
 Recently, several research groups have utilized 2-oxo-1,3,2-oxazaphosphorinanes 
(1), which contain a bulky N-substituent, as a novel class of chiral auxiliaries and as such 
has led to new methods in asymmetric synthesis. Denmark prepared a series of racemic 
and enantiomerically pure 2-oxo-1,3,2 oxazaphosphorinanes. The diastereoselectivity of 
alkylation of the derived anions was examined as a function of ring substitution.3 In a later 
study the diastereoselectivity of the alkylations was found to be sensitive to the size of the 
N-substituents.  
N
PO
Ph
H
H3C
N
PO
Ph
H
H3C
O
Me
SS
  i) t-BuL i / THF / -70oC
ii) MeI / -70oC
93%, 97% de
(2)
(3)
O
 
Scheme 1 
 The highest diastereoselectivity was obtained with 2-benzyl-6-methyl-2-oxo-1,3,2-
oxazaphosphorinane (2), which contained a N-isopropyl substituent (Scheme 1).4 These 
stereoselective alkylation reactions were subsequently utilized for the highly 
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 enantioselective synthesis of both α-alkylphosphonates4,5 and  α-alkoxyphosphonates.5 
The same  group also reported that racemic 2-allyl-1,3,2-oxazaphosphorinanes-2-oxides 
underwent extremely diastereoselective Michael additions to cyclic enones.6 Εvans 
reported the enantioselective aldol reactions of a chiral 2-oxo-2-propionyl-1,3,2-
oxazaphosphorinane.7  
N
PO O
CH3
N
PO O
CH3
RMgBr / THF / CuI
 TMSCl / TMEDA /
  -78 to -40oC / Ar
d.e = 66 - 82%
yield = 31 - 61%
(4) (SP,RC) (5)
R = i-Pr, t-Bu, Ph
R
 
Scheme 2 
 In the last few years Afarinkia and co-workers have made further advances in this 
field of asymmetric synthesis. They reported the first examples of diastereoselective 
additions of carbon nucleophiles to 2-(prop-2-enyl)-2-oxo-1,3,2-oxazaphosphorinanes.8-10 
Subsequently, the same group reported diastereoselective additions of carbon nucleophiles 
to enantiopure 2-(prop-2-enyl)-2-oxo-1,3,2-oxazaphosphorinanes (4) (Scheme 2).11  The 
major addition product (5) was obtained as a single diastereomer following 
recrystallization from petroleum ether. Afarinkia also recently reported that N-substituted 
2-oxo-2-propyl-1,3,2-oxazaphosphorinanes undergo diastereoselective alkylations.12,13  A 
- 3 - 
 review of this group's work on asymmetric induction utilizing such chiral 
oxazaphosphorinane auxiliaries has recently been published.14 
1.1.2 Additions to Activated Imines 
 The enantioselective addition of carbon nucleophiles to imines15,16 is a very 
important process due to the predominant role that chiral amines play in biologically 
important systems. Furthermore, chiral amines are also useful building blocks for the 
synthesis of various medicinal compounds such as rivastigmine (6), tamsulosin (7), 
indanorex (8) and repaglinide (9) (Figure 2).17 
NMe
O
O
N
Me
Me
(6)
OMe
2 2
N
H
Me
O
OEt
(7 )
OH
Et
NH2
N
H
N
O
OEt
COOH
 (8)
(9)
Et
SO NH
 
Figure 2 
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  The chiral environment of the starting imine plays an important role for the success 
of the enantioselective additions. A variety of chiral auxiliaries have been utilized for 
nucleophilic addition to imines. These include imines derived from chiral amines (10-13), 
imines derived from chiral hydrazones (14-16), imines derived from chiral N-sulfinamines 
(17,18), imines derived from chiral oxime ethers (19) and imines derived from chiral 
nitrones (20) (Figure 3). 
R N
Ph
R N
OH
R N
OR
O
N R
H
PivO
PivO
OPiv
OPiv
R N
Me
N
Me
R N
Me
N
OH
R
N
N
R H
N
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O
p-Tol
R H
N
S
O
t-But
H OMe
R N
O Ph
R
R = Me, Et, Pr, i-Pr
R N
OPG
O
(10)
(16)
(15)
(14)
(13)
(12)
(11)
(17)
(18)
(19)
(20)
OHMe
 
Figure 3 
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  Sulfinimines (N-sulfinylimines) are an important class of activated imines that 
display unique reactivity and stereoselectivity due to the presence of the chiral N-sulfinyl 
group. Over the last ten years Davis has made major advances in asymmetric synthesis 
using p-toluenesulfinimines. He has completed the asymmetric synthesis of many natural 
products and bioactive molecules using this methodology. One example is the synthesis of 
human leukocyte elastase inhibitor, DMP 777, (24). 18 DIBAL-H reduction of the ketone-
derived sulfinimine (21) afforded the corresponding sulfonamide (22) in 80% yield and 
86% de. Removal of the sulfinyl group with TFA gave (23) which is a chiral amino unit 
found in (24) (Scheme 3).
p-Tol
S
N
O
O
O
DIBAL
THF / -40oC
NH
S
p-Tol
O
O
O
NH2
O
O
i) 1% TFA / MeOH
ii) NaOH
HN
O
O
N
O
O
O
N
N
Me
O
(21) (22)
(23)(24)
80% 86% de
Scheme 3 
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  Ellman recently developed an efficient synthesis of support-bound tert-
butanesulfinimines (25) and demonstrated the utility of this linker for the asymmetric 
synthesis of enantioenriched amines (27) (Scheme 4).19
S
N R
S
N
H
R
Et
ClH3N R
Et
HCl,
MeOH
EtMgBr / Et2O
CH2Cl2 / -20
oC
R = i-Pr, Ph, Bn, C6H4-4-OMe
(25)
(27)
(26)
Yields = 90-95%
ee  = 78-94 %
O O
 
Scheme 4 
 Asymmetric 1,4-additions of carbon nucleophiles, especially diethyl zinc, to 
activated imines have been extensively studied.20 Soai et al reported the enantioselective 
addition of diethylzinc to N-diphenylphosphinoylimines using chiral diimines, chiral 
diamines and chiral dendrimers as chiral ligands.21 Another example of the use of chiral 
dendrimers as efficient chiral ligands for the enantioselective addition of diethylzinc to N-
diphenylphosphinoylimines was recently reported.22 Chiral amino alcohols (29) have also 
been utilized for the enantioselective addition of diethylzinc to N-diphenylphosphinoyl 
imines (28) (Scheme 5).23,24 Enantiomerically enriched N-diphenylphosphinylamines (30) 
with excellent enantioselectivities (up to 94% ee) were obtained. 
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 Ph N
P
O
Ph
Ph
N
Et2Zn / Toluene / r.t
Ph N
H
P
O
Ph
Ph
90 %, 94% ee
Et
HO Me
Bn
(28)
(29)
(30)
Ph Ph
 
Scheme 5 
 Recently, Charette et al. have investigated the bis(phosphine) monoxide ligand (32) 
for the copper-catalyzed diorganozinc addition to N-phosphinoylimines (31). This 
required lower catalyst loading and the resulted phosphinoylamines (33) obtained in 
higher yields and enantiomeric excess (Scheme 6).17,25 The same group reported the 
reaction mechanism in a recent paper. 26 
P
P
O
R1 H
N
P
O
Ph
Ph
Cu(OTf)2 /  (6 mol %)
R22Zn (2 equiv) / toluene / 
          0oC / 16-20 h
Me
Me
R1 R2
HN
P
O
Ph
Ph
Yield = 80-98%
ee = 89-99%
(33)(31)
(32)
R1 = Ph, 4-Me-C6H4, 4-Cl-C6H4,
        4-MeO-C6H4, 1-naphthyl, 
       2-naphthyl, 2-furyl, cyclopropyl
R2 = Et, Me, n-Bu, i-Pr  
Scheme 6 
- 8 - 
 1.2 Objectives and Work Plan 
1.2.1 Objectives 
The major objective of this work is to develop suitable methodology in order to 
prepare the 2-imino-1,3,2-oxazaphosphorinane (34). This novel class of activated imines 
are potential precursors to many biologically important building blocks such as α-
aminophosphonic acids (35), α-amino acids (36), β-amino acids (37), α-branched amines 
(38), α,α-dibranched amines (39) and aziridines (40) (Figure 4).  
CO2H
R1
R2
H2N
R1
H2N
O
OR4
R3
R2OR4
+M-O
R3
R3MgBr Et2AlCN
(R3O)2P(O)H P OR3H2N
O
OR3
R2R
1
[H]R
1
R2H2N
OR4
+M-O
Br
NH
R2
R1
(35)
(40)
(38)
(37)
(36)
R3
R1
R2
H2N
(39)
HO2C
N P
O
O
N
Ph R
1
R2(34)
 
Figure 4 
The chiral phosphorus auxiliary attached to the imine functional group has several 
important advantages. The electron withdrawing nature of the P=O moiety will increase 
the electrophilicity of the imine. This will enable the additions of nucleophiles to be 
- 9 - 
 conducted at a lower temperature, with the potential of enhanced selectivity. Also, as this 
chiral auxiliary contains a phosphorus atom 31P NMR can be utilized to follow the course 
of the addition reactions. Completion of the reaction is clearly indicated by the 
disappearance of the 31P NMR of the starting imine. Also, 31P NMR can act as a powerful 
tool to determine the stereochemical outcome of the addition reaction. Comparison of the 
integrals of the two 31P NMR peaks, for the two diastereomeric addition products, is a 
simple yet precise method to determine the diastereoselectivity of this reaction.  
1.2.2 Work Plan 
 This project primarily focuses upon the development of suitable methodology for 
the synthesis of 2-imino-2-oxo-1,3,2-oxazaphosphorinane (34), a novel class of activated 
imine. The retrosynthetic pathway is outlined below (Figure 5). It is envisaged that imine 
(34) can be synthesized by the condensation of an aldehyde or ketone (41) and 
phosphorodiamidate (42), which in turn can be synthesized from the corresponding 
phosphoramidochloridate (43). This six membered oxazaphosphorinane ring system can 
be obtained from the cyclization of aminoalcohol (44). This in turn can be obtained from 
aminoester (45). Finally, this can be derived from α-methylbenzylamine (46) which is 
commercially available both in racemic and enantiomerically pure forms. 
 The aminoester (45)27, amino alcohol (44)28 and 2-chloro-2-oxo-1,3,2-
oxazaphosphorinane (43)29,30 have been previously reported in the literature. However, 
there are no reports of either the 2-amino-2-oxo-1,3,2-oxazaphosphorinane (42) and the 
- 10 - 
 target 2-imino-2-oxo-1,3,2-oxazaphosphorinane (34). Thus, they are novel compounds 
and so represent important synthetic targets. 
N P
O
O
NH2
Ph
N
PO O
Ph
O
R2 R1
+
NH
OH
Ph
(42)
NH
OMe
Ph
O
H2N
Ph
(43)
(46)
(45) (44)
(41)
N P
O
O
N
Ph
(34)
R1
R2
Cl
 
Figure 5 
 The proposed procedure for the synthesis of the racemic 2-imino-2-oxo-1,3,2-
oxazaphosphorinane (52) is outlined below (Scheme 7). Condensation of (RS)-α-
methylbenzylamine (47) with methyl acrylate yields the aminoester (48) which can be 
reduced by using lithium aluminium hydride. The resulting aminoalcohol (49) upon 
treatment with phosphorus oxytrichloride can be converted to the 
phosphoramidochloridate (50), which yields the corresponding phosphorodiamidate (51) 
upon reaction with liquid ammonia. The key reaction in our synthetic sequence is the 
condensation of (51) with benzaldehyde. Based upon various literature precedents, which 
- 11 - 
 will be outlined later, we envisaged that Lewis acid catalyst will be required in order to 
yield our synthetic target (52). 
N P
O
O
NH2
Ph
N
P
O
Cl
O
Ph
O
H Ph
(49)(47)
N P
O
O
N
Ph
O
Ph NH2 Ph N
H
OMe
O LiAlH4
Ph N
H
POCl3
Et3N
NH3
(48)
(50)
(52)
(51)
Lewis Acid
Ph
OH
OMe
 
Scheme 7 
 Following preparation of the benzaldehyde derived aldimine (52) the next objective 
is to use the same methodology to synthesize the corresponding enantiomerically pure 2-
imino-2-oxo-1,3,2-oxazaphosphorinane derivatives (X=H) (53a) and (54a). It is 
envisaged that other 4-substituted aromatic aldehydes could be employed to yield the 
related derivatives (53b,c) and (54b,c) (Figure 6). 
 Ketimines are a more challenging synthetic target due to the poor electrophilicity of 
ketones compared to aldehydes. Thus, ketimines (55) and (56) derived from acetophenone 
are our next synthetic target (Figure 7).  
 
- 12 - 
 N P
O
O
N
Ph
Xa X = H
b X= Ph
c X = Br
(54)
N
P
N
O
Ph
H
(53)
X
 
Figure 6 
N P
O
O
N
Ph
(56)
CH3
N
P
N
O
Ph
CH3
(55)
 
Figure 7 
 
- 13 - 
 CHAPTER 2  
2. SYNTHESIS  
2.1 Synthesis of 2-amino-2-oxo-1,3,2-oxazaphosphorinanes 
2.1.1 Results and Discussion  
 The conversion of racemic α-methylbenzylamine (47) to the corresponding 
phosphoramidochloridates (50a,b,c,d) is shown below (Scheme 8). 1,4-Addition of (47) 
with methyl acrylate occurred smoothly upon heating under reflux in methanol for three 
hours. Following removal of the solvent under reduced pressure the crude was purified by 
flash chromatography to yield the aminoester (48) with a 78% yield. The ester (48) was 
then reduced to the corresponding aminoalcohol (49) by heating under reflux in THF with 
3.5 equivalents of lithium aluminum hydride.  
 The resulting amino alcohol (49) was then reacted with phosphorus oxytrichloride 
and triethylamine, as an acid scavenger, according to the known literature procedure. Four 
stereoisomers were obtained as two sets of enantiomeric pairs (50a,b) and (50c,d).  31P 
NMR was utilized to follow the course of this cyclization reaction. Phosphorus 
oxytrichloride has a distinctive 31P NMR peak at 5.12 ppm. The disappearance of this 
peak in the 31P NMR of the crude reaction mixture clearly indicated completion of the 
reaction. Two new signals appeared at 9.60 ppm and 10.15 ppm respectively. Comparison 
of their integrals indicated that the two pairs of enantiomers were formed in a 1:10 ratio. 
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 It should be emphasized at this point a very important advantage resulting from 
utilization of the N-α-methylbenzyl substituent. As this moiety contains a chiral center, 
the separation of the two diastereomeric phosphoramidochloridates (50a,b) and (50c,d) 
was possible using flash chromatography (Scheme 9).  
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 The major diastereoisomer (50a,b) was used to carry out the subsequent steps of the 
synthesis. Due to the unavailability of liquid ammonia, ammonium hydroxide (NH4OH) 
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 was heated in order to generate ammonia for the conversion of (50a,b) to 
phosphorodiamidate (51a,b) (Scheme 10). The reaction mixture was stirred overnight and 
31P NMR of the crude product showed complete conversion into the desired 
phosphorodiamidate (51a,b). X-ray analysis confirmed the absolute stereochemistry and 
the conformation of this reaction product (see section 2.2). 
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 The same approach was utilized with the enantiopure reagents (R)-(+)-α-
methylbenzylamine (57) (Scheme 11) and (S)-(-)-α-methylbenzylamine (60) (Scheme 
12). However, in both cases the diastereomeric mixture of phosphoramidochloridates, 
(50a,d) and (50b,c) respectively, were purified by recrystallization rather than column 
chromatography. Recrystallization of phosphoramidochloridates, (50a,d), from toluene 
and hexane, yielded the major diastereomer (50a) in improved yield (Scheme 11). 
Likewise, recrystallization of phosphoramidochloridates (50b,c) yielded the major 
diastereomer (50b) (Scheme 12). The resulting mother liquor was subjected to flash 
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 chromatography which resulted in more of the major diasteroemer (50b) and a small 
amount of the minor diasteroemer (50c) being obtained. 
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  Both phosphoramidochloridates (50a) and (50b) then underwent ammonolysis to 
yield the corresponding phosphorodiamidates (51a) and (51b) respectively (Scheme 13).  
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 2.2 X-ray Conformational Analysis of 2-oxo-1,3,2-oxazaphosphorinanes 
2.2.1 Introduction 
Study of the conformation of 2-oxo-1,3,2-oxazaphosphorinanes is important for 
three reasons. It is of basic interest to understand the effect on the conformational 
properties arising from the replacement, and substitution, of the carbon atoms of a 
cyclohexane ring by heteroatoms.31,32 Secondly, this ring system is found in a number of 
anticancer drugs such as cyclophosphamide (1a), isophosphamide (1b), 
triphophosphamide (1c) (Figure 1) and therefore an understanding of this ring’s preferred 
conformation contributes to the interpretation of these drugs’ structure–activity 
relationships. 2 Finally, the conformation of 2-oxo-1,3,2-oxazaphosphorinanes is the basis 
of a number of models which predict asymmetric reactions of chiral phosphonamidates 
such as (63)4,5 and (64)14 (Figure 8).  
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Figure 8 
Thus, we were interested in obtaining information about the conformation of our 
target molecules phosphoramidochloridate (43) and phosphorodiamidate (42) (Figure 9). 
This will enable us to develop a conformational model of the corresponding imine (34) 
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 which will assist us in explaining the stereochemical outcome of our proposed 1,4-adition 
reactions. 
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2.2.2 Results and Discussion  
 The cyclization of enantiomerically pure amino alcohol (59) with phosphorus 
oxytrichloride yielded two diastereomeric phosphoramidochloridates (50a) and (50d) 
(Scheme 14) in a 1:10 ratio, as determined by 31P NMR of the crude product. It should be 
noted that there are no reports of X-Ray structures for these compounds in the literature. 
Thus, it was not clear which of these two diastereoisomers was the major and which was 
the minor reaction product.  
 Recrystallization of this diastereomeric mixture from toluene and hexane yielded the 
major phosphoramidochloridate in a diastereomerically pure form as white needles. We 
were able to obtain a single crystal X-ray of this diastereomer which unambiguously 
confirmed the major reaction product was diastereomer (50a). 
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 This X-ray (Figure 10) clearly indicates that the exo cyclic P=O is equatorial and the 
chlorine is axial. Note that the hydrogen and both methyl and phenyl groups of the N-α-
methylbenzyl substituent have been removed for the sake of clarity. 
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Figure 10 
Amonolysis of the enantiomeric pair (50a,b) was followed by the usual work up, 
and yielded the crude phosphorodiamidate (51a,b) (Scheme 15).  
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 Purification was attempted by triturating the crude product with toluene. To our 
delight pure crystals of the enantiomeric pair (51a,b) were obtained and X-ray analysis 
unambiguously confirmed its structure. One half of the unit cell is showed for the sake of 
clarity (Figure 11). Once again the exo cyclic P=O is equatorial and the amino group is 
axial. 
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 2.2.3 Literature Precedents  
 Upon obtaining X-ray crystal structures for phosphoramidochloridate (50a) and 
phosphorodiamidate (51a) a more comprehensive literature survey was conducted. X-ray 
crystal structures were found for the following 2-oxo-1,3,2-oxazaphosphorinanes (Figure 
12). Bentrude reported the conformation of 5,5-dimethyl-2-(dimethylamino)-2-oxo-1,3,2-
oxazaphosphorinane (65).33 Stec reported the first crystal structure of 2-(S)-2-fluoro-oxo-
3-[(S)-α-methylbenzyl]-1,3,2-oxazaphosphorinane (66).34 Recently, Afarinkia obtained 
X-ray crystal structures for the 2-aroyl-3-N-benzyl derivative (67) and the 2-aroyl-3-N-
benzhydryl derivative (68).35 In all of the above examples the exo cyclic P=O was found 
to be equatorial whereas the other group was axial.  
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 Thus, our brief conformational study yielded the same findings as previous studies 
on the related 2-oxo-1,3,2-oxazaphosphorinanes outlined above. The full crystal structures 
of (50a) and (51a), including the N-α-methylbenzyl substituent, have been placed in 
appendix A. 
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 2.3 Synthesis of 2-imino-2-oxo-1,3,2-oxazaphosphorinanes 
2.3.1 Synthesis of Aldimines  
 The key reaction in our synthetic sequence is the conversion of phosphorodiamidate 
(42) to our target 2-imino-2-oxo-1,3,2-oxazaphosphorinanes (34) (Scheme 16). Our 
objective was to develop methodology that would allow for efficient condensation of both 
aromatic aldehydes and ketones which are less electrophilic. 
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Scheme 16 
 As our 2-imino-2-oxo-1,3,2-oxazaphosphorinanes (34) are a novel class of activated 
imines we sought literature precedents for the synthesis of related imine systems. Lovely 
and co-workers reported the preparation of N-diphenylphosphinoylimine (70) from the 
reaction of diphenylphosphinic amide (69) with benzaldehyde (Scheme 17).36 However,  
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 this method was only suitable for the condensation of aromatic aldehydes and occurred 
only with moderate overall yields (35-58%). 
 Over the last 10 years extensive efforts had been made to develop various flexible 
approaches to the synthesis of N-sulfinylimines (72) from the corresponding N-
sulfinamides (71a,b) (Scheme 18). Importantly, the utilization of titanium (IV) ethoxide 
as Lewis acid has allowed the synthesis of both aldimines and ketimines.18,19 
S
O
R2
Ti(OEt)4
R NH2
S
O
R N
(72)(71)
R1 R2
R1
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b  R = t-Bu
R1, R2 = H, alkyl, aryl
O
 
(Scheme 18) 
 Thus, it was decided to try both of these methods for the synthesis of our target 2-
imino-2-oxo-1,3,2-oxazaphosphorinanes (34). 
2.3.1.1 Results and Discussion   
 Our first target was to synthesize the imine (53a) derived the condensation of the 
homochiral phosphorodiamidate (51b) with benzaldehyde (Scheme 19). Initially, we 
chose to employ the same reaction conditions that Ellman and Davis utilized for the 
synthesis of N-sulfinylimines.18,19 Five equivalents of Lewis acid, Ti(OEt)4, were used in 
order to activate the imine and to drive the reaction to completion. The reaction was 
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 heated under reflux before quenching the cooled reaction mixture with water. The crude 
was then filtered through a pad of celite in order to remove the titanium (IV) salt. 
 1H NMR and 31P NMR was employed to study the outcome of this reaction. Imine 
formation was confirmed by the appearance of a characteristic doublet, due to 3JPH 
coupling, at 9.16 ppm in the 1H NMR spectrum. Comparison of the integration of the 
phosphorodiamidate 31P peak (11.41 ppm) and the new imine 31P peak (9.67 ppm) allowed 
for the conversion to be determined. 
2.3.1.1.1 Solvent Effect  
 Our initial experiments were conducted on a 10 mmol scale. When the reagents 
were heated under reflux with THF as the solvent a very low conversion was observed 
(entry 1, Table 1). Also five additional minor peaks were observed in the crude 31P NMR. 
Thus, it was clear that the reaction was not clean. The same reaction was attempted at 
room temperature (entry 2, Table 1). However, both 1H NMR and 31P NMR indicated that 
the reaction still was not clean.  
 We were very happy to observe a cleaner reaction when dichloromethane was used 
as the solvent (entries 3 and 4, Table 1). Importantly, only two peaks for the 
phosphorodiamidate starting material and imine product were observed in the crude 31P 
NMR. Likewise, the 1H NMR spectrum clearly showed the characteristic doublet of the 
imine at 9.16 ppm. However, the conversion was still not satisfactory (37-40%).  
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Table 1 The effect of solvent and temperature on the conversion of (51b) to (53a) 
Entry 
 
Solvent 
 
Temp 
 
Time 
(hrs) 
Conversiona
(%) 
1 THF Reflux 18 10 
2 THF 25 ºC 26 23 
3 DCM Reflux 18 40 
4 DCM 25 ºC 24 37 
a  as indicated by 31P NMR of the crude product. 
 Thus, it was decided to further optimize this reaction using dichloromethane as the 
solvent prior to attempting purification by column chromatography.  
2.3.1.1.2 Reaction Time and Ratios of Starting Material  
 Variation of the reaction time did not lead to a linear increase in the conversion 
(entries 1, 2 and 3, Table 2). The maximum conversion obtained was 70% following 
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 heating under reflux for 12 hours (entry 2, Table 2). Utilization of two equivalents of 
benzaldehyde led to an improvement in the conversion (entries 3 and 4, Table 2). Upon 
heating under reflux for 24 hours the conversion increased to 86% (entry 5, Table 2).  
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Table 2 The effect of reaction time and the ratio of reagents  
on the conversion of (51b) to (53a) 
Entry 
 
Ratio 
P(O)NH2 : PhCHO : Ti(OEt)4
Time 
(hrs) 
Conversiona
(%) 
1 1    :    1    :    5 4 50 
2 1    :    1    :    5 12 70 
3 1    :    1    :    5 24 61 
4 1    :    2    :    5 12 83 
5 1    :    2    :    5 24 86 
a  as indicated by 31P NMR of the crude product. 
 The non-linear improvement in conversion (entries 1, 2 and 3, Table 2) prompted us 
to speculate whether this reaction was reversible.  
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 2.3.1.1.3 Effect of Lewis Acid 
 We then investigated the effect of the Lewis acid upon the conversion of (51b) to 
(53a) (Scheme 21). None of the Lewis acids used gave a conversion higher than the 86% 
conversion observed with Ti(OEt)4 (entry 1, Table 3). The closely related Ti(OiPr)4  gave 
77% conversion (entry 2, Table 3) whereas the strongly Lewis acidic TiCl4 only resulted 
in a 43% conversion (entry 4, Table 3). The addition of 4Å Molecular sieves as an 
additional drying reagent proved unsuccessful with a much lower conversion being 
observed (entry 3, Table 3). Anhydrous copper (II) sulfate has been utilized as an 
effective drying agent and catalyst for the synthesis of N-sulfinamide derived aldimines.19 
However, no conversion was observed following heating under reflux for 24 hours in 
dichloromethane. Both 1H and 31P NMR indicated only the presence of recovered starting 
material (entries 5, and 6, Table 3). 
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 Table 3 The effect of Lewis acid on the conversion of (51b)to (53a) 
Entry 
 
Lewis Acid 
 
Ratio 
P(O)NH2 : PhCHO : Lewis Acid 
Conversiona
(%) 
1 Ti(OEt)4 1 : 2 : 5 86 
2 Ti(OiPr)4 1 : 2 : 5 77 
3 Ti(OEt)4  +  
4Å Mol. Sieves  
1 : 2 : 5 18 
4 TiCl4 
b 1 : 2 : 5 43 
5 CuSO4 1 : 1.1 : 2.2 0 
6 CuSO4 1 : 2 : 5 0 
a  as indicated by 31P NMR of the crude product. 
b Three equivalents of triethylamine (with respect to the TiCl4) were utilized as an acid  
   scavenger. 
2.3.1.1.4 Workup Procedure  
 Following a review of our results it was found that there was a large difference in 
the conversion for reactions which had been heated under reflux in dichloromethane for 
24 hours (entry 1, Table 4). We postulated that the reaction could be reversible with the 
aldimine product (53a) reverting back to the phosphorodiamidate (51b) and 
benzaldehyde. Thus, it was decided to follow the reaction more closely using 31P NMR. 
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 After 24 hours of heating under reflux an aliquot was taken from the reaction mixture 
prior to work up. 31P NMR showed the presence of only one peak at 9.67 ppm for the 
aldimine (53a). Importantly, no peak for the phosphorodiamidate starting material (51b) 
was observed which indicated that the reaction had gone to completion. This finding 
seemed to indicate that some hydrolysis of the aldimine product occurred during our work 
up procedure. Thus, a modified work up consisting of removing the solvent under reduced 
pressure was adopted. 31P NMR analysis of the crude reaction mixture showed only one 
peak for the product indicating 100% conversion (entry 2, Table 4).  
 The excess Ti(OEt)4 was readily removed from the product following column 
chromatography. However, it was more difficult to remove the excess benzaldehyde from 
the aldimine product and so the isolated yields were low. It should be noted that the 
aldimine product (53a) was very sensitive to hydrolysis. This was often observed even 
when left in CDCl3 in a NMR tube for a few hours. Thus, it had to be stored without 
solvent under a nitrogen atmosphere in the fridge or used immediately for subsequent 
transformations (see 2.4). 
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 Table 4 The effect of the Work Up on the conversion of (51b)to (53a) 
Entry 
 
WorkUp Procedure 
 
31P NMR 
 
Conversiona
(%) 
1 Quenching with water 2 peaks 60 – 86 
2 Removing solvent under reduced pressure One peak 100 
a  as indicated by 31P NMR of the crude product. 
 
2.3.2 Synthesis of Aldimines Derived from other Benzaldehyde Derivatives   
 Several other 4-substituted benzaldehyde derivatives (R= Ph, Br) were reacted with 
phosphorodiamidate (51b) using the modified work up procedure. The corresponding 
aldimines (53b) and (53c) were obtained (Scheme 23 and Table 5). In each case 31P NMR 
showed 100% conversion. The 1HNMR showed the distinctive doublet of the imine 
proton due to 3JPH coupling (27.1–32.3 Hz).  
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Table 5 Aldimines derived from 4-substituted benzaldehydes 
1H NMR (–N=CHPh) 31P NMR Entry R 
δH /ppm 3JPH/Hz δP /ppm 
Conversiona
(%) 
1 H 9.16 32.3 9.67 100 
2 Br 9.03 27.1 9.34 100 
3 Ph 9.12 32.3 9.82 100 
a  as indicated by 31P NMR of the crude product. 
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 2.3.3 Synthesis of Ketimines  
2.3.3.1 Results and Discussion   
 Ketimines are a more challenging synthetic target due to the poor electrophilicity of 
ketones compared to aldehydes. Lovely and co-workers were unable to apply their TiCl4 
mediated condensations to the synthesis of ketimines derived from diphenylphosphinic 
amide (69). Only the competing aldol condensation product and recovered starting 
material were obtained.36 However, Davis successfully utilized a large excess of Ti(OEt)4 
for the synthesis of ketimine (73) derived from N-sulfinamide (71a) (Scheme 24). Ten 
equivalents of Lewis acid and five equivalents of acetophenone were required in order for 
the reaction to go to completion. Importantly, no competing aldol condensation products 
were observed.37 
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 We utilized the same conditions as Davis for our attempted ketimine formation. 
Unfortunately, a very low conversion was observed when dichloromethane was used as 
the solvent (entry 1, Table 6). This was far lower than was observed using similar 
conditions for our aldimine formation (entry 1, Table 4). In order to improve the rate of 
reaction we wanted a higher boiling point solvent. As outlined previously THF did not 
yield a clean reaction (entries 1 and 2, Table 1). Thus, we decided to use toluene and were 
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 delighted to observe a dramatic improvement in the conversion (entry 2, Table 6). When 
toluene was used in conjunction with the modified work up procedure 100% conversion 
was achieved (entry 3, Table 6). This ketimine (56) was more stable than the 
corresponding aldimine (53a). However, once again the excess acetophenone proved 
difficult to separate from the ketimine product (56). Thus, following chromatography the 
isolated yield was only 44%.  
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Table 6 Synthesis of ketimine (56) derived from acetophenone 
Entry Solvent Work up 
Conversion 
(%) 
Isolated 
Yield 
% 
1 DCM Quenching with water 17 9 
2 Toluene Quenching with water 81 42 
3 Toluene Removing solvent  
under reduced pressure 100 44 
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 2.3.4 Synthesis of aldimines using toluene as the solvent 
 Our success in the ketimine synthesis caused us to revaluate our aldimine synthesis. 
We wanted to further optimize our best result (entry 1, Table 7) especially by reducing the 
required amount of benzaldehyde. When toluene was used as the solvent, with the same 
ratio of reagents, the reaction was complete after only 8 hours of heating under reflux 
(entry 2, Table 7). Heating under reflux in toluene for 24 hours, with only 1.1 equivalents 
of benzaldehyde, resulted in 95% conversion (entry 3, Table 7).  
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Table 7 The effect of solvent on the conversion of (51a) to (54a) 
Entry Solvent  
Ratio 
P(O)NH2 : PhCHO : Ti(OEt)4
Time  
(Hrs) 
Conversiona
(%) 
1 DCM 1:2:5 24 100 
2 Toluene 1:2:5 8 100 
3 Toluene 1:1.1:5 24 95 
 a  as indicated by 31P NMR of the crude product. 
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  Thus, our most successful aldimine synthesis proceeded by heating under reflux in 
toluene for 24 hours, with only 1.1 equivalents of benzaldehyde. Purification using 
column chromatography yielded the desired aldimine (54a) with an isolated yield of 80% 
(Scheme 27). 
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 Due to the lack of time no further optimization was possible. However, we envisage 
that there is still scope to improve this reaction by reducing the amount of Lewis acid 
necessary for the reaction to go to completion. Thus, purification of our target aldimines 
by column chromatography will be easier. This will enable more material to be obtained 
for our 1,4-additions reactions to these aldimines. 
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 2.4 Asymmetric 1,4-additions of Et2AlCN to 2-imino-2-oxo-1,3,2-
oxazaphosphorinanes 
 
2.4.1 Results and Discussion   
Two diastereomerically pure 2-imino-2-oxo-1,3,2-oxazaphosphorinanes, (53a) and 
(54a), were synthesized (Figure 13).  
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Figure 13 
Unfortunately, these aldimines were not very stable at room temperature and 
underwent decomposition to the phosphorodiamidate starting material and benzaldehyde. 
This was clearly observed by both 1H NMR and 31P NMR. When this became apparent we 
decided to use these aldimines immediately after they were synthesized for subsequent 
transformations.  
We wanted to investigate the diastereoselectivity of the 1,4 addition reaction of 
cyanide nucleophiles to this novel class of activated imine. Incorporation of the cyano 
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 functional could allow for the synthesis of enantiomerically α-amino acids (36) following 
hydrolysis and removal of the chiral auxiliary (Scheme 28). 
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Several small scale 1,4-additions of diethylaluminium cyanide to the (PR, CS) 
aldimine (53a) were attempted (Scheme 29). At first the addition was carried out at 25 ºC 
in THF using two equivalents of diethylaluminium cyanide (entry 1, Table 8). However, it 
was very difficult to follow the reaction by TLC as the spot for the addition product had a 
very similar Rf to that of the starting aldimine. After 2 hours, the reaction was quenched 
with saturated NH4Cl solution and the crude product was analyzed. 1H NMR showed that 
the doublet for the imine proton at 9.16 ppm had disappeared. Thus, the reaction had gone 
to completion as was also confirmed by 31P NMR. Not only had the aldimine peak (9.67 
ppm) disappeared but there were two new peaks at 7.59 and 7.87 ppm, respectively. 
Integration of these two peaks indicated that the ratio of these peaks was 0.40 : 1.0.  
Thus, our first attempted 1,4-addition had proceeded with a moderate level of 
diastereoseletivity (43% de). The diastereoselectivity improved slightly (48% de) when 
the reaction was repeated at - 10 ºC (entry 2, Table 8). However, when we attempted to 
purify the crude reaction mixture by chromatography crystals started to form. Thus, this 
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 mixture was recrystallized from ethyl acetate and hexane. We were delighted to obtain the 
major addition product in a diastereomerically pure form, albeit in a very small quantity 
(16mg) due to the small scale of this reaction. Thus, at this stage we were unable to assign 
this major product as either (76a) or (76b). We hope to repeat this reaction on a larger 
scale so that sufficient diastereomerically pure material will be obtained. This will enable 
the absolute stereochemistry to be assigned following X-ray analysis.  
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Scheme 29 
 
Table 8 1,4-Addition of Et2AlCN to (53a) 
Entry Time  Temp % d.e 
1 2 h 25 ºC 43 
2 12 h -10 ºC 48 
 
Several small scale 1,4-additions of diethylaluminium cyanide to the (PS, CR) 
aldimine (54a) were also attempted (Scheme 29). Once again problems were encountered 
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 in trying to follow the reaction by TLC. However, lower diastereoselectivities were 
observed for this (PS, CR) aldimine (54a) (entries 1 and 2, Table 9).   
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Scheme 30 
Table 9 1,4-Addition of Et2AlCN to (54a) 
Entry Time  Temp % d.e 
1 15 min -10 ºC 18 
2 12 h -40 ºC 36 
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 CHAPTER 3  
3. EXPERIMENTAL 
3.1 General Methods and Experimentation 
All the starting materials were used as received including solvents, without further 
purification unless otherwise stated. Specially dried (anhydrous) solvents were used where 
necessary. Glassware for moisture sensitive reactions were oven dried at 120-140 °C for 
at least three hours and cooled in a desiccator prior to use. Some of the reactions were run 
under inert atmosphere of nitrogen as stated. 
 Thin layer chromatography was frequently used to monitor reactions and to give 
qualitative determination of sample purity. TLC analysis carried out on Merck silica gel; 
60 F254 plates and spots were visualized under a spectroline UV lamp operating at short 
and long wavelength ranges. Visualization was improved by dipping plates into alkaline 
potassium permanganate solution, followed by drying in a blast of hot air. Purification of 
the products was carried out either by recrystallization or by flash column 
chromatography. The column was packed with silica gel (Merk 9358) 60 mesh. Ethyl 
acetate, petroleum ether (boiling fraction 60-80) and hexane were used as eluting solvent, 
in volume-by-volume ratios as stated. 
 1H NMR spectra were recorded using a Joel Lamda 500 MHz spectrometer. Spectra 
were internally referenced to using TMS. Deuterated chloroform (CDCl3) was used as the 
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 deuterated solvent for all spectra. Multiplicities are reported as singlet (s), doublet (d), 
triplet (t), quartet (q) or multiplet (m). All chemical shifts are reported in parts per million 
(ppm) and coupling constants (J) in hertz (Hz). 13C NMR spectra where run on the same 
machine operating at 125 MHz under the same conditions. 31P NMR spectra were run on 
the same machine operating at 202.35 MHz. 85% Phosphoric acid (H3PO4) in DMSO was 
used as internal standard for referencing 31P NMR spectra. 
3.2 Experimental Procedures 
Ph N
H
OMe
O
(48)  
Methyl 3-(1-phenylethylamino)propanoate (48) 
±-(RS)-α-Methylbenzylamine (1.41 g, 11.6 mmol), methylacrylate (0.960 g, 1.00 ml, 11.6 
mmol) and methanol (15.0 ml) were added together and heated under reflux for 5 hours. 
Flash chromatography (petroleum ether : ethyl acetate 20:80) afforded methyl 3-(1-
phenylethylamino)propanoate (48) (1.80 g, 78%) as a colorless oil. 
Ph N
H
OMe
(58)
O
 
Methyl 3-((R)-1-phenylethylamino)propanoate (58) 
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 (R)-α-Methylbenzylamine (4.11 g, 34.0 mmol), methylacrylate (3.00 g, 3.10 ml, 34.0 
mmol) and methanol (30.0 ml) were added together and heated under reflux for 5 hours. 
Evaporation of the solvent under reduced pressure yielded methyl 3-((R)-1-
phenylethylamino)propanoate (58) (6.71 g, 95%) as colorless oil. 
Ph N
H
OMe
(61)
O
 
Methyl 3-((S)-1-phenylethylamino)propanoate (61) 
(S)-α-Methylbenzylamine (4.12 g, 34.0 mmol), methylacrylate (2.92 g, 3.10 ml, 34.0 
mmol) and methanol (30.0 ml) were added together and heated under reflux for 5 hours. 
Evaporation of the solvent under reduced pressure yielded methyl 3-((S)-1-
phenylethylamino)propanoate (61) (6.70 g, 95%) as colorless oil. 
Ph N
H
OH
(49)  
3-(1-phenylethylamino)propan-1-ol (49) 
Methyl 3-(1-phenylethylamino)propanoate (48) (1.90 g, 9.10 mmol) was dissolved in 
THF (50 ml). Lithium aluminum hydride (1.73 g, 45.6 mmol) was added over 30 min. 
The reaction mixture was refluxed for 3 hours and then quenched (water/15% NaOH) 
after warming to room temperature. The precipitate was removed by filtration through a 
bed of celite. The crude product was purified by gradual elution with (CHCl : 3 
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 MeOH/NH  98:2) to remove the less polar product and then the polarity was increased 
(90:10) and the resulted 
3
3-(1-phenylethylamino)propan-1-ol (49) (1.75 g, 91%) was 
isolated as a yellow oil. 
Ph N
H
OH
(59)  
3-((R)-1-phenylethylamino)propan-1-ol (59) 
Methyl 3-((R)-1-phenylethylamino)propanoate (58) (5.53 g , 26.7 mmol) was dissolved in 
THF (130 ml). Lithium aluminum hydride (3.44 g, 90.7 mmol) was added slowly over 15 
min. The reaction mixture was heated under reflux for 5 hours. The reaction mixture was 
refluxed for 5 h and then quenched (water/15% NaOH) after warming to room 
temperature. The precipitate was removed by filtration through a bed of celite and the 
solvent removed under reduced pressure to yield 3-((R)-1-phenylethylamino)propan-1-ol 
(59) (4.10 g, 91%) as a yellow oil.  
Ph N
H
OH
(62)  
3-((S)-1-phenylethylamino)propan-1-ol (62) 
Methyl 3-((S)-1-phenylethylamino)propanoate (61) (5.53 g, 26.7 mmol ) was dissolved in 
THF (130 ml). Lithium aluminum hydride (3.44 g, 90.7 mmol) was added over 15 min. 
The reaction mixture was refluxed for 5 hours and then quenched (water/15% NaOH) 
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 after warming to room temperature. The precipitate was removed by filtration through a 
bed of celite and the solvent removed under reduced pressure to yield 3-((S)-1-
phenylethylamino)propan-1-ol (62) (4.10 g, 91%) as a yellow oil. 
(50a) Racemic
N
PO O
Ph
(50c) Racemic
N
PO O
Ph
Cl Cl
 
Racemic (2R)-chloro-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (50a) 
and its diastereomer racemic (2R)-chloro-3-[(S)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane (50c): 
To a cooled solution (-10ºC) of phosphorus oxytrichloride (1.27 g, 0.800 ml, 8.30 mmol) 
and  triethylamine (1.70 g, 2.40 ml, 16.6 mmol) in toluene (50 ml) was added a solution of 
3-(1-phenylethylamino)propan-1-ol (49) (1.50 g, 8.30 mmol) in toluene (10 ml). The 
temperature was maintained at -10 to 0 ºC during the addition and for additional 30 min. 
After being allowed to warm to room temperature, the mixture was filtered through celite. 
Evaporation of the solvent under reduced pressure yielded the crude product as colorless 
semicrystalline mixture (2.0 g, 91%). The two diastereoisomers were separated by column 
chromatography using ethyl acetate / petroleum ether solution (25:75) and yielded the 
major diastereomer racemic (2R)-chloro-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane (50a) (0.92 g, 42%) as a white semicrystalline solid, δP (202.35 
MHz, CDCl3) 9.60; δH (500 MHz; CDCl3) 1.50 (3H, d, J 7.00 Hz, CHCH3), 1.65-1.68 
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 (1H, m, one of CH2CH2O), 1.92-2.02 (1H, m, remaining one of CH2CH2O), 2.47-2.64 
(1H, m, one of NCH2CH2), 2.92-3.03 (1H, m, remaining one of NCH2CH2), 4.16-4.33 
(2H, m, CH2O), 4.77-4.83 (1H, m, CHCH3), 7.17-7.27 (5H, m, C6H5); δC (125 MHz; 
CDCl3) 19.1, 26.2, 42.4, 55.7, 70.4, 127.4, 127.5, 128.1, 138.9; and the minor 
diastereomer racemic (2R)-chloro-3-[(S)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane (50c) (0.18 g, 8%) as a brown oil, δP (202.35 MHz, CDCl3) 10.15; δH 
(500 MHz; CDCl3) 1.56 (3H, d, J 7.00 Hz, CHCH3), 1.66-1.70 (1H, m, one of CH2CH2O), 
1.86-1.96 (1H, m, remaining one of CH2CH2O), 2.79-2.90 (1H, m, one of NCH2CH2), 
3.05-3.02 (1H, m, remaining one of NCH2CH2), 4.38-4.47 (2H, m, CH2O), 5.13-5.21 (1H, 
m, CHCH3), 7.27-7.43 (5H, m, C6H5); δC (125 MHz; CDCl3) 14.1, 26.0, 40.3, 53.0, 70.7, 
127.3, 127.5, 128.3, 139.8 
N
PO
Ph
O
(50c)(50b)
N P
O
Cl
O
Ph
Cl
 
(2S)-Chloro-3-[(S)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (50b) and its 
diastereomer (2R)-chloro-3-[(S)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane 
(50c) : 
To a cooled solution (-10ºC) of phosphorus oxytrichloride (5.10 g, 3.10 ml, 33.1 mmol) 
and triethylamine (6.70 g, 9.30 ml, 66.1 mmol ) in toluene (175 ml) was added a solution 
of 3-((S)-1-phenylethylamino)propan-1-ol (62) (5.90 g, 33.1 mmol) in toluene (25.0 ml). 
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 The temperature was maintained at -10 to 0 ºC during the addition and for additional 30 
min. After being allowed to warm to room temperature, the mixture was filtered through 
celite. Evaporation of the solvent under reduced pressure yielded the crude product as 
colorless semicrystalline mixture (7.40 g, 89%). This was dissolved in toluene (5.00 ml). 
Hexane (10.0 ml) was added portionwise and the solution was stored at 4ºC for 4 hour. 
The major diastereomer (2S)-chloro-3-[(S)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane (50b) (5.30 g, 62%) was obtained as a colorless needles: m.p 71-73 
ºC; δP (202.35 MHz, CDCl3) 9.63; δH (500 MHz; CDCl3) 1.62 (3H, d, J 7.00 Hz, CHCH3), 
1.73-1.76 (1H, m, one of CH2CH2O), 2.06-2.17 (1H, m, remaining one of CH2CH2O), 
2.65-2.72 (1H, m, one of NCH2CH2), 3.00-3.09 (1H, m, remaining one of NCH2CH2), 
4.31-4.43 (2H, m, CH2O), 4.90-4.93 (1H, m, CHCH3), 7.28-7.44 (5H, m, C6H5). The 
mother liquor was concentrated and flash chromatography using ethyl acetate / petroleum 
ether solution (25:75) afforded the minor diastereomer (2R)-chloro-3-[(S)-α-
methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (50c) (0.18 g, 2%) as brown oil; δP 
(202.35 MHz, CDCl3) 10.22; δH (500 MHz; CDCl3) 1.48 (3H, d, J 7.00 Hz, CHCH3), 
1.59-1.62 (1H, m, one of CH2CH2O), 1.82-1.92 (1H, m, remaining one of CH2CH2O), 
2.77-2.83 (1H, m, one of NCH2CH2), 2.98-3.00 (1H, m, remaining one of NCH2CH2), 
4.31-4.35 (2H, m, CH2O), 5.10-5.18 (1H, m, CHCH3), 7.19-7.35 (5H, m, C6H5); δC (125 
MHz; CDCl3) 15.04, 26.75, 41.30, 53.80, 71.92, 127.95, 128.3, 129.12, 140.8 
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 (50a)
N
PO O
Ph
Cl
 
(2R)-Chloro-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (50a) 
To a cooled solution (-10ºC) of phosphorus oxytrichloride (3.85 g, 2.34 ml, 25.1 mmol) 
and triethylamine (5.10 g, 7.03 ml, 50.2 mmol) in toluene (150 ml) was added a solution 
of 3-((R)-1-phenylethylamino)propan-1-ol (59) (4.50g, 25.1 mol) in toluene (25 ml). The 
temperature was maintained at -10 to 0 ºC during the addition and for additional 30 min. 
After being allowed to room temperature the mixture was filtered through celite. 
Evaporation of the solvent at reduced pressure gave a colorless semicrystalline mixture 
(6.20 g, 95%). This was dissolved in toluene (4.00 ml), hexane (8.00 ml) was added 
portionwise and the solution was stored at 4ºC for 4 hours. (2R)-Chloro-3-[(R)-α-
methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (50a) (4.00 g, 62%) was obtained as 
colorless needles, m.p 71-73 ºC; δP (202.35 MHz, CDCl3) 9.63; δH (500 MHz; CDCl3) 
1.60 (3H, d, J 7.00 Hz, CHCH3), 1.71-1.74 (1H, m, one of CH2CH2O), 1.98-2.15 (1H, m, 
remaining one of CH2CH2O), 2.65-2.72 (1H, m, one of NCH2CH2), 2.99-3.12 (1H, m, 
remaining one of NCH2CH2), 4.28-4.44 (2H, m, CH2O), 4.88-4.94 (1H, m, CHCH3), 7.26-
7.38 (5H, m, C6H5).  
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 (51a) Racemic
N P
NH2
O
Ph
O
 
Racemic (R)-amino-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (51a) 
Racemic (2R)-chloro-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (50a) 
(0.500 g, 1.90 mmol) was dissolved in dichloromethane (20 ml) and the solution was 
cooled to -63 ºC. Excess liquid ammonia was added to the reaction vessel and the solution 
was stirred at -63°C for one hour and then allowed to warm to room temperature and 
stirred overnight. The crude was filtered through a bed of celite and washed with ethyl 
acetate (5.00 ml) , the filtrate was evaporated and recrystallized from hot toluene to yield 
racemic 2(R)-amino-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (51a) (0.40 
g, 87%) as a white solid; δP (202.35 MHz, CDCl3) 11.41; δH (500 MHz; CDCl3) 1.53 (3H, 
d, J 7.05 Hz, CHCH3), 1.64-1.67 (2H, CH2CH2O), 2.74-2.81 (3H, m, NH2 and one of 
NCH2CH2), 2.95-3.02 (1H, m, remaining one of NCH2CH2), 4.17-4.28 (2H, m, CH2O), 
4.99-5.06 (1H, m, CHCH3), 7.24-7.53 (5H, m, C6H5); δC (125 MHz; CDCl3) 16.8, 26.5, 
40.5, 52.7, 67.3, 126.9, 127.7, 128.0, 141.2  
(51a)
N P
NH2
O
Ph
O
 
2(R)-Amino-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (51a) 
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 (2R)-Chloro-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (50a) (4.20 g, 16.0 
mmol) was dissolved in dichloromethane (40 ml) and the solution was cooled to -63 ºC. 
Excess liquid ammonia was added to the reaction vessel and the solution was stirred at -
63°C for one hour and then allowed to warm to room temperature and stirred overnight. 
The crude was filtered  through a bed of celite and washed with ethyl acetate (20.0 ml) , 
the filtrate was evaporated and recrystallized from hot toluene to yield 2-(R)-amino-3-
[(R)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (51a) (3.25 g, 84%) as a white 
solid; δP (202.35 MHz, CDCl3) 11.41; δH (500 MHz; CDCl3) 1.53 (3H, d, J 7.05 Hz, 
CHCH3), 1.64-1.70 (2H, CH2CH2O), 2.73-2.84 (3H, m, NH2 and one of NCH2CH2), 2.95-
3.02 (1H, m, remaining one of NCH2CH2), 4.17-4.29 (2H, m, CH2O), 4.99-5.05 (1H, m, 
CHCH3), 7.24-7.56 (5H, m, C6H5); δC (125 MHz; CDCl3) 17.9, 27.5, 41.7, 53.9, 68.4, 
128.1, 128.7, 129.1, 142.1  
(51b)
N
PO
2
Ph
O
NH
 
2(S)-Amino-3-[(S)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (51b) 
(2S)-Chloro-3-[(S)-α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (50b) (3.10 g, 16.0 
mmol) was dissolved in dichloromethane (40.0 ml) and the solution was cooled to -63 ºC. 
Excess liquid ammonia was added to the reaction vessel and the solution was stirred at -
63°C for one hour and then allowed to warm to room temperature and stirred overnight. 
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 The crude was filtered through a bed of celite and washed with ethyl acetate (20.0 ml) , 
the filtrate was evaporated and recrystallized from hot toluene to yield 2(S)-amino-3-[(S)-
α-methylbenzyl]-2-oxo-1,3,2-oxazaphosphrinane (51b) (2.23 g, 81%) as a white solid; δP 
(202.35 MHz, CDCl3) 11.51; δH (500 MHz; CDCl3) 1.53 (3H, d, J 7.00 Hz, CHCH3), 
1.61-1.71 (2H, CH2CH2O), 2.73-2.80 (1H, m, one of NCH2CH2), 2.80 (2H, broad, m, 
NH2), 2.95-3.02 (1H, m, remaining one of NCH2CH2), 4.17-4.29 (2H, m, CH2O), 4.99-
5.06 (1H, m, CHCH3), 7.14-7.53 (5H, m, C6H5). 
(53a)
N
PO
N
Ph
O
H
Ph
 
3-[(S)-α-Methylbenzyl]-2(R)-oxo-2-[(phenylmethylene)amino]-1,3,2-
oxazaphosphorinane (53a) 
Method (A): 
In an oven-dried single-necked 50 ml round-bottom flask equipped with a magnetic 
stirring bar and reflux condenser was placed 2(S)-amino-3-[(S)-α-methylbenzyl]-2-oxo-
1,3,2-oxazaphosphrinane (51b) (77.0 mg, 0.321 mmol). Then it was dissolved in 
dichloromethane (7.00 ml). Benzaldehyde (68.1 mg, 66.0 µl, 0.641 mmol) and titanium 
(IV) ethoxide (400 µl, 1.60 mmol) were added to the solution by syringe. The reaction 
mixture was refluxed for 24 h and cooled to 0 °C, H2O (7.00 ml) was added, and the 
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 solution was filtered through celite and washed with ethyl acetate (10.0 ml). The phases 
were separated, and the organic phase was washed with brine (5.00 ml), dried over 
magnesium sulphate, filtered through celite. The solvent was removed under reduced 
pressure. Flash chromatography (EtOAc : hexane, 25:75) afforded 3-[(S)-α-
methylbenzyl]-2(R)-oxo-2-[(phenylmethylene)amino]-1,3,2-oxazaphosphorinane (53a) 
(0.041 g, 39%) as a colorless oil; δP (202.35 MHz, CDCl3) 9.67; δH (500 MHz; CDCl3) 
1.39 (3H, d, J 7.00 Hz, CHCH3), 1.68-1.71 (1H, m, one of CH2CH2O), 1.94-2.04 (1H, m, 
remaining one of CH2CH2O), 2.81-2.88 (1H, m, one of NCH2CH2), 3.32.-3.3.37 (1H, m, 
remaining one of NCH2CH2), 4.33-4.39 (1H, m, one of CH2O), 4.56-4.62 (1H, m, 
remaining one of CH2O), 5.02-5.08 (1H, m, CHCH3), 7.24-7.96 (10H, m, ArH), 9.16 (1H, 
d, J 32.3 Hz, NCHPh). 
Method (B): 
In an oven-dried single-necked 50 ml round-bottom flask equipped with a magnetic 
stirring bar and reflux condenser was placed 2(S)-amino-3-[(S)-α-methylbenzyl]-2-oxo-
1,3,2-oxazaphosphrinane (51b) (68.5 mg, 0.285 mmol). Then it was dissolved in 
dichloromethane (7.00 ml). Benzaldehyde (60.6 mg, 58 µl, 0.570 mmol) and titanium (IV) 
ethoxide (300 µl, 1.43 mmol) were added to the solution by syringe. The reaction mixture 
was refluxed for 24 h and cooled to room temperature. The solvent was removed under 
reduced pressure. Flash chromatography (EtOAc : hexane, 25:75) afforded 3-[(S)-α-
methylbenzyl]-2(R)-oxo-2-[(phenylmethylene)amino]-1,3,2-oxazaphosphorinane (53a) 
(0.090 g, 96%) as white semicrystalline solid. 
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3-[(R)-α-Methylbenzyl]-2(S)-oxo-2-[(phenylmethylene)amino]-1,3,2-
oxazaphosphorinane (54a) 
A similar procedure using 2-(R)-amino-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane (51a) (246 mg, 1.025 mmol), dichloromethane (20.0 ml), 
benzaldehyde (218 mg, 209 µl, 2.05 mmol) and titanium (IV) ethoxide (1076 µl, 5.15 
mmol) and yielded 3-[(R)-α-methylbenzyl]-2(S)-oxo-2-[(phenylmethylene)amino]-1,3,2-
oxazaphosphorinane (54a) (0.108 g, 32 %) as a colorless oil; δP (202.35 MHz, CDCl3) 
9.63; δH (500 MHz; CDCl3) 1.39 (3H, d, J 6.95 Hz, CHCH3), 1.68-1.71 (1H, m, one of 
CH2CH2O), 1.94-2.04 (1H, m, remaining one of CH2CH2O), 2.81-2.88 (1H, m, one of 
NCH2CH2), 3.32.-3.3.37 (1H, m, remaining one of NCH2CH2), 4.33-4.39 (1H, m, one of 
CH2O), 4.56-4.62 (1H, m, remaining one of CH2O), 5.02-5.08 (1H, m, CHCH3), 7.23-
7.96 (10H, m, ArH), 9.16 (1H, d, J 32.2 Hz, NCHPh). 
(56)
N P
N
O
Ph CH3
Ph
O
 
3-[(R)-α-Methylbenzyl]-2(S)-oxo-2-[(1-phenylethylidene)amino]-1,3,2-
oxazaphosphorinane (56) 
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 Method (A): 
In an oven-dried single-necked 50 ml round-bottom flask equipped with a magnetic 
stirring bar and reflux condenser was placed 2-(R)-amino-3-[(R)-α-methylbenzyl]-2-oxo-
1,3,2-oxazaphosphorinane (51a) (60.0 mg, 0.250 mmol). Then it was dissolved in toluene 
(10.0 ml). Acetophenone (150.2 mg, 146 µl, 1.25 mmol) and titanium (IV) ethoxide (525 
µl, 2.50 mmol) were added to the solution by syringe. The reaction mixture was refluxed 
for 24 h and cooled to 0 °C, H2O (8.00 ml) was added, and the solution was filtered 
through celite and washed with ethyl acetate (20.0 ml). The phases were separated, and 
the organic phase was washed with brine (5.00 ml), dried over magnesium sulphate, 
filtered through celite. The solvent was removed under reduced pressure. Flash 
chromatography (EtOAc : hexane, 25:75) afforded 3-[(R)-α-methylbenzyl]-2(S)-oxo-2-
[(1-phenylethylidene)amino]-1,3,2-oxazaphosphorinane (56) (0.030 g, 42%) as a yellow 
oil. δP (202.35 MHz, CDCl3) 5.37; δH (500 MHz; CDCl3) 1.43 (3H, d, J 7.05 Hz, 
CHCH3), 1.59-1.62 (1H, m, one of CH2CH2O), 1.90-1.99 (1H, m, remaining one of 
CH2CH2O), 2.79-2.88 (1H, m, one of NCH2CH2), 2.88-2.90 (3H, d, J 2.45 Hz, PhCCH3), 
3.27.-3.32 (1H, m, remaining one of NCH2CH2), 4.28-4.35 (1H, m, one of CH2O), 4.47-
4.53 (1H, m, remaining one of CH2O), 5.11-5.17 (1H, m, CHCH3), 7.20-8.06 (10H, m, 
ArH); δC (125 MHz; CDCl3) 15.45, 22.67, 27.0, 40.73, 52.1, 69.3, 126.9, 127.5, 127.8, 
128.0, 128.4, 132.0, 139.6, 140.4, 141.7, 177.9 
Method (B): 
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 In an oven-dried single-necked 50 ml round-bottom flask equipped with a magnetic 
stirring bar and reflux condenser was placed 2-(R)-amino-3-[(R)-α-methylbenzyl]-2-oxo-
1,3,2-oxazaphosphorinane (51a) (111.5 mg, 46.4 mmol). Then it was dissolved in toluene 
(15.0 ml). Acetophenone (279 mg, 271 µl, 232 mmol) and titanium (IV) ethoxide (975 µl, 
464 mmol) were added to the solution by syringe. The reaction mixture was refluxed for 
24 h and cooled to room temperature. The solvent was removed under reduced pressure. 
Flash chromatography (EtOAc : hexane, 25:75) afforded 3-[(R)-α-methylbenzyl]-2(S)-
oxo-2-[(1-phenylethylidene)amino]-1,3,2-oxazaphosphorinane (56) (0.070 g, 44%) as a 
yellow oil. 
N
PO
HN
Ph
O
CN
N
PO
HN
Ph
O
CN
(76a) (76b)
and
PhPh
 
2(S)-[(S)-(Cyanophenylmethyl)amino]-3-[(S)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane (76a) and 2(S)-[(R)-(cyanophenylmethyl)amino]-3-[(S)-α-
methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (76b) 
In an oven-dried single-necked 50 ml round-bottom flask fitted with a rubber septum and 
equipped with a magnetic stirring bar under nitrogen was placed a solution 3-[(S)-α-
methylbenzyl]-2(R)-oxo-2-[(phenylmethylene)amino]-1,3,2-oxazaphosphorinane (53a) 
(70 mg, 213 mmol) in THF (6 ml) and cooled to -10C. Diethylaluminium cyanide (427, 
427 mmol) was added by syringe and the reaction mixture was stirred at -10 for 2 hours 
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 and then stirred overnight at room temperature. The reaction was quenched with a 
saturated solution of ammonium chloride (5 ml), the suspension was filtered through 
celite, washed with brine and extracted with ethyl acetate (2 x 10 ml), dried with 
magnesium sulfate and concentrated to give a diastereomeric mixture of the title 
compounds (76a) and (76b) with ratio of (1 : 0.35). Crystallization from ethyl acetate and 
hexane (30:70) afforded the major addition product as a single diastereomer (100% de) 
(0.016 g, 22 %); δP (202.35 MHz, CDCl3) 7.72; δH (500 MHz; CDCl3) 1.55 (3H, d, J 7.00 
Hz, CHCH3), 1.62-1.69 (1H, m, one of CH2CH2O), 1.72-1.76 (1H, m, remaining one of 
CH2CH2O), 2.79-2.87 (1H, m, one of NCH2CH2), 3.03-3.09 (1H, m, remaining one of 
NCH2CH2), 3.31 (1H, t, J 9.9 Hz, NH), 4.135-4.31 (2H, m, CH2CH2O), 5.01-5.06 (1H, m, 
CHCH3), 5.50 (1H, t, J 9.9 Hz, HNCHCN),  7.26-7.62 (10H, m, for both Ar-H); δC (125 
MHz; CDCl3) 17.2, 26.2, 40.6, 47.5, 53.1, 67.7, 118.9, 126.7, 127.5, 127.9, 128.4, 129.31, 
129.39, 135.0, 140.4 IR (cm-1) :  3441.00 (broad), 3206.81 (sharp), 2920.72 (sharp ), 2240 
(weak), 1491 (sharp), 1235.79 (sharp). 
N P
HN
O
Ph
Ph
CN
(77a)
N P
HN
O
Ph
Ph
CN
(77b)
and
O O
 
2(R)-[(R)-(Cyanophenylmethyl)amino]-3-[(R)-α-methylbenzyl]-2-oxo-1,3,2-
oxazaphosphorinane (77a) and 2(R)-[(S)-(cyanophenylmethyl)amino]-3-[(R)-α-
methylbenzyl]-2-oxo-1,3,2-oxazaphosphorinane (77b) 
- 58 - 
 In an oven-dried single-necked 50 ml round-bottom flask fitted with a rubber septum and 
equipped with a magnetic stirring bar under nitrogen was placed a solution 3-[(R)-α-
methylbenzyl]-2(S)-oxo-2-[(phenylmethylene)amino]-1,3,2-oxazaphosphorinane (54a) 
(70.0 mg, 213 mmol) in THF (10 ml) and cooled to -40 C. Diethylaluminiumcyanide (427 
, 427 mmol) was added by syringe and the reaction mixture was stirred at -10 for 2 hours 
hen stirred overnight at room temperature. The reaction was quenched with a saturated 
solution of ammonium chloride (5 ml), the suspension was filtered through celite, washed 
with brine and extracted with ethyl acetate (2 x 10 ml), dried with magnesium sulfate and 
concentrated to give of diastereomeric mixture, with a (1 : 0.48) ratio, of the title 
compounds (77a) and (77b) (0.074 g, 98%) with the same spectroscopic data as (76a) and 
(76b). 
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 APPENDIX A 
X-RAY CRYSTALLOGRAPHIC DATA 
 
a(Å)                    6.6544(8) 
b                        11.0658(13)    
c                         17.612(2)       
V  (Å3)             1296.9(3)              
System    Orthorhombic     
Space group    P212121   
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 cell_measurement_temperature (K)   296 
Radiation_wavelength (Å)                  0.71073  
diffrn_radiation_type              MoK\α 
theta_min(°)             2.17 
theta_max(°)           28.32 
reflns_number               3149 
reflns_number_ >2sigma(I)                2528 
refine_ls_number_parameters       146 
R_factor_ gt (2 σ)               0.0458 
wR_factor_gt (2 σ)           0.1043 
Bond distances (Å) 
P1 O1 1.4509(18) .   
P1 O2 1.553(2) .   
P1 N1 1.6102(18) .   
P1 Cl1 2.0260(9) .   
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 O2 C1 1.464(4) .   
N1 C3 1.467(3) .   
N1 C5 1.484(3) .   
C1 C2 1.486(4) .   
C2 C3 1.499(3) .   
C4 C5 1.525(4) .   
C5 C6 1.504(4) .   
C6 C7 1.379(4) .   
C6 C11 1.386(4) .   
C7 C8 1.380(5) .   
C8 C9 1.368(7) .   
C9 C10 1.345(7) .   
C10 C11 1.395(5) .   
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 Bond angles (°) 
O1 P1 O2 114.73(13) . .   
O1 P1 N1 116.53(11) . .   
O2 P1 N1 105.15(10) . .   
O1 P1 Cl1 109.44(9) . .   
O2 P1 Cl1 101.51(9) . .   
N1 P1 Cl1 108.28(7) . .   
C1 O2 P1 119.73(17) . .   
C3 N1 C5 116.77(17) . .   
C3 N1 P1 118.89(14) . .   
C5 N1 P1 120.64(15) . .   
O2 C1 C2 110.3(2) . .   
C1 C2 C3 112.4(2) . .   
N1 C3 C2 111.4(2) . .   
N1 C5 C6 111.45(18) . .   
N1 C5 C4 107.8(2) . .   
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 C6 C5 C4 115.1(2) . .   
C7 C6 C11 118.0(3) . .   
C7 C6 C5 123.1(3) . .   
C11 C6 C5 118.8(3) . .   
C6 C7 C8 120.9(4) . .   
C9 C8 C7 119.8(4) . .   
C10 C9 C8 120.8(4) . .   
C9 C10 C11 119.8(5) . .   
C6 C11 C10 120.6(4) . .    
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a(Å)                    5.4055(6)  
b                        10.4565(12)  
c                        11.7639(13)  
α (°)                    105.774(2)  
β                     102.677(2)  
γ                    95.832(2)  
V  (Å3)                      615.01(12)  
System    Triclinic 
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 Space group     P-1 
cell_measurement_temperature     295 
Radiation_wavelength (Å)                   0.71073  
diffrn_radiation_type              MoK\α 
theta_min(°)              1.86  
theta_max(°)            28.25 
reflns_number               5415 
reflns_number_ >2sigma(I)                2408  
refine_ls_number_parameters       154 
R_factor_ gt (2 σ)               0.0455  
wR_factor_gt (2 σ)           0.1164 
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 Bond distances (Å) 
P1 O1 1.4711(13) .  
P1 O2 1.5889(14) .  
P1 N1 1.6298(16)   
P1 N2 1.6583(13)   
N2 C3 1.477(2) .   
N2 C5 1.493(2) .   
O2 C1 1.446(3) .   
C1 C2 1.511(3) .   
C2 C3 1.518(3) .   
C4 C5 1.527(3) .   
C5 C6 1.527(2) .   
C6 C7 1.372(3) .   
C6 C11 1.389(3) .   
C7 C8 1.387(3) .   
C8 C9 1.372(3) .   
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 C9 C10 1.352(4) .   
C10 C11 1.388(3) .   
 Bond angles (°) 
O1 P1 O2 110.60(8) . .   
O1 P1 N1 111.77(9) . .   
O2 P1 N1 106.26(9) . .   
O1 P1 N2 113.70(8) . .   
O2 P1 N2 102.02(7) . .   
N1 P1 N2 111.80(8) . .   
C3 N2 C5 115.05(12) . .   
C3 N2 P1 117.27(10) . .   
C5 N2 P1 117.86(10) . .   
C1 O2 P1 118.26(12) . .   
O2 C1 C2 109.61(17) . .   
C1 C2 C3 111.30(16) . .   
N2 C3 C2 110.72(15) . .   
- 71 - 
 N2 C5 C4 113.56(14) . .   
N2 C5 C6 108.84(13) . .   
C4 C5 C6 114.39(16) . .   
C7 C6 C11 117.15(18) . .   
C7 C6 C5 119.72(15) . .   
C11 C6 C5 123.12(18) . .   
C6 C7 C8 121.40(19) . .   
C9 C8 C7 120.5(2) . .   
C10 C9 C8 119.1(2) . .   
C9 C10 C11 120.8(2) . .   
C10 C11 C6 121.1(2) . .  
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 Appendix B 
NMR SPECTRA 
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